Pharmacotherapy of essential thrombocythaemia: economic considerations

Author： Griesshammer Martin Langer Christian

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.9, 2003-09, pp. : 1499-1505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Essential thrombocythaemia in children: is a treatment needed?

By Randi Maria Luigia Putti Maria Caterina

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1009-1014

Informa Healthcare

Access to resources Recommend Favorite

Anagrelide: A Review of its Use in the Management of Essential Thrombocythaemia

By Wagstaff Antona J. Keating Gillian M.

Drugs, Vol. 66, Iss. 1, 2006-01 ,pp. : 111-131

Adis International

Access to resources Recommend Favorite

Polycythaemia Vera and Essential Thrombocythaemia: Current Treatment Strategies

By Penninga Elisabeth I. Bjerrum Ole W.

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2173-2187

Adis International

Access to resources Recommend Favorite

Current treatment practice for essential thrombocythaemia in adults

By Griesshammer M. Bangerter M. Grünewald M.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 385-393

Informa Healthcare

Access to resources Recommend Favorite

Hydroxycarbamide: Essential thrombocythaemia transformation to biphenotypic leukaemia in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1285, 2010-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite